Skip to content
Webinar Cafe
Upcoming

SITC Science in Context: PD-1/VEGF Bispecifics: Where does the field head next?

Society for Immunotherapy of Cancer (SITC) · Healthcare

About this webinar

SITC’s webinar examines scientific, clinical, regulatory, and investor perspectives on PD-1/VEGF bispecifics, including survival endpoints, toxicity, the rationale for dual immune and angiogenic targeting, and commercial considerations.

Discussion

Sign in to join the discussion

Related webinars